Hypercalcemia Malignancy Factor (1-34), amide, human peptide
Not For Human Use, Lab Use Only.
Cat.#: 309256
Special Price 430.1 USD
-
Product Name
Hypercalcemia Malignancy Factor (1-34), amide, human peptide
-
Documents
Batch to batch variation of the purity
-
Sequence Shortening
AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA
-
Sequence
H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-OH
-
Length (aa)
34
-
Peptide Purity (HPLC)
97.6%
-
Molecular Formula
C180H287N57O48
-
Molecular Weight
4017.61
-
Source
Synthetic
-
Form
Powder
-
Description
V.Paspaliaris et al. showed that daily administration of pTHrP (1-34) to rats was anabolic on bone by increasing bone formation. This treatment could inhibit the rapid decline in bone formation due to denervation.
-
Storage Guidelines
Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual: Handling and Storage of Synthetic Peptides
-
References
- J.M.Moseley et al., Proc. Natl. Acad. Sci. USA, 84, 5048 (1987)
- B.E.Kemp et al., Science, 238, 1568 (1987)
- L.J.Suva et al., Science, 237, 893 (1987)
- V.Paspaliaris et al., Bone, 16, 141S, abstract (1995)
-
About TFA salt
Trifluoroacetic acid (TFA) has a significant impact on peptides due to its role in the peptide synthesis process.
TFA is essential for the protonation of peptides that lack basic amino acids such as Arginine (Arg), Histidine (His), and Lysine (Lys), or ones that have blocked N-termini. As a result, peptides often contain TFA salts in the final product.
TFA residues, when present in custom peptides, can cause unpredictable fluctuations in experimental data. At a nanomolar (nM) level, TFA can influence cell experiments, hindering cell growth at low concentrations (as low as 10 nM) and promoting it at higher doses (0.5–7.0 mM). It can also serve as an allosteric regulator on the GlyR of glycine receptors, thereby increasing receptor activity at lower glycine concentrations.
In an in vivo setting, TFA can trifluoroacetylate amino groups in proteins and phospholipids, inducing potentially unwanted antibody responses. Moreover, TFA can impact structure studies as it affects spectrum absorption.
-
Molar Concentration Calculator
-
Dilution Calculator
-
Percent Concentration Calculator
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Peptide Property
- Analysed Sequence:H-AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-OH
- Chemical Formula:C180H287N57O48
- Sequence length:34
- Extinction coefficient:0 M-1cm-1
- GRAVY:-0.39
- Mw average:4017.54
- Theoretical pI:9.87
- Data Source:Peptide Property Calculator
GRAVY = grand average of hydropathy
X: Hydrophobic uncharged residues, like F I L M V W A and P
X: Basic residues, like R K H
X: Acidic residues, like D E
X: Polar uncharged residues, like G S T C N Q and Y
Related Products / Services
• Peptide Services: NovoPro's peptide synthesis services include standard chemical peptide synthesis, peptide modification, peptide libraries, and recombinant peptide expression.
• Standard Peptide Synthesis: NovoPro offers quality peptides at the most competitive prices in the industry, starting at $3.20 per amino acid. NovoPro provides PepBox – Automatic Quote Tool for online price calculation.
• Peptide Modifications: NovoPro offers a wide range of peptide modification services including isotope labeling (2H, 15N, and 13C), multiple disulfide bonds, multiple phosphorylations, KLH, BSA, ovalbumin, amidation, acetylation, biotin, FITC, etc.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"